ophthalmic formulation and its use and method for improving, reducing or treating presbyopia

摘要

"Ophthalmic formulation and its use and method for ameliorating, reducing or treating presbyopia" summarizes a pharmaceutical formulation having an effective amount of a parasympathomimetic agent comprising pilocarpine, or a pharmaceutically acceptable salt thereof and one or more? 1 adrenergic agonists or antagonists is revealed. The pharmaceutical formulation may allow treatment of conditions that adversely affect a patient's visual acuity, including presbyopia. A method of using the disclosed ophthalmic formulation to treat or ameliorate presbyopic symptoms is also disclosed. 1/1